Acquisition talks for Metsera that played out this year culminated in an agreement with Pfizer, which agreed to buy the obesity drug developer for $4.9 billion. Novo Nordisk, a finalist in that pursuit, is positioning itself as a deal spoiler with a new unsolicited offer that shells out much more upfront cash.
The post Novo Nordisk Swoops In With $6.5B Bid to Top Pfizer’s M&A Deal With Obesity Biotech Metsera appeared first on MedCity News.
![Can iPhones Get Viruses? Security Experts Answered [+Warning Signs] – Bitdefender](https://i2.wp.com/res.cloudinary.com/glide/image/fetch/https%3A%2F%2Flh3.googleusercontent.com%2FJ6_coFbogxhRI9iM864NL_liGXvsQp2AupsKei7z0cNNfDvGUmWUy20nuUhkREQyrpY4bEeIBuc%3Ds0-w300-rw?w=0&resize=0,0&ssl=1 "Can iPhones Get Viruses? Security Experts Answered [+Warning Signs] – Bitdefender")
Can iPhones Get Viruses? Security Experts Answered [+Warning Signs] – Bitdefender
Can iPhones Get Viruses? Security Experts Answered [+Warning Signs] Bitdefender
